Author

Yvonne M. Hoedemaekers

Observed names: Hoedemaekers, Y.M., Hoedemaekers, YM, Hoedemaekers, Yvonne, Hoedemaekers, Yvonne M., Y M Hoedemaekers, Y M Hoedemakers, Y. M. Hoedemaekers, Y. M. Hoedemakers, Y.M. Hoedemaekers, Yvonne Hoedemaekers, Yvonne M Hoedemaekers, Yvonne M. Hoedemakers

Institutions: Radboud University Nijmegen, Radboud University Medical Center

Observed institutions: University Medical Center Groningen, Radboud University Nijmegen, University of Groningen, Erasmus MC, Amsterdam UMC Location University of Amsterdam, Radboud University Medical Center, University Medical Center Utrecht, Máxima Medisch Centrum, Erasmus University Rotterdam

ORCID: 0000-0002-5335-641X

Observed ORCID: 0000-0002-5335-641X

OpenAlex ID: A5040745551

Mutations in SMAD3 cause a syndromic form of aortic aneurysms and dissections with early-onset osteoarthritis

2011 · Ingrid M B H van de Laar, Rogier A Oldenburg, et al. · Nature Genetics · 691

Genetics, Clinical Features, and Long-Term Outcome of Noncompaction Cardiomyopathy

2018 · Jaap I. van Waning, Kadir Caliskan, et al. · Journal of the American College of Cardiology · 314

The Importance of Genetic Counseling, DNA Diagnostics, and Cardiologic Family Screening in Left Ventricular Noncompaction Cardiomyopathy

2010 · Yvonne M. Hoedemaekers, Kadir Caliskan, et al. · Circulation Cardiovascular Genetics · 245

HCN4 Mutations in Multiple Families With Bradycardia and Left Ventricular Noncompaction Cardiomyopathy

2014 · Annalisa Milano, Alexa M.C. Vermeer, et al. · Journal of the American College of Cardiology · 205

A mutation update for the FLNC gene in myopathies and cardiomyopathies

2020 · Job A. J. Verdonschot, Els K. Vanhoutte, et al. · Human Mutation · 190

Transethnic Genome-Wide Association Study Provides Insights in the Genetic Architecture and Heritability of Long QT Syndrome

2020 · Najim Lahrouchi, Rafik Tadros, et al. · Circulation · 139

Cardiac -myosin heavy chain defects in two families with non-compaction cardiomyopathy: linking non-compaction to hypertrophic, restrictive, and dilated cardiomyopathies

2007 · Y. M. Hoedemaekers, K. Caliskan, et al. · European Heart Journal · 128

Diastolic Abnormalities as the First Feature of Hypertrophic Cardiomyopathy in Dutch Myosin-Binding Protein C Founder Mutations

2009 · Michelle Michels, Osama I.I. Soliman, et al. · JACC. Cardiovascular imaging · 103

Disease penetrance and risk stratification for sudden cardiac death in asymptomatic hypertrophic cardiomyopathy mutation carriers

2009 · Michelle Michels, Osama I.I. Soliman, et al. · European Heart Journal · 94

Compound heterozygous or homozygous truncating MYBPC3 mutations cause lethal cardiomyopathy with features of noncompaction and septal defects

2014 · Marja W Wessels, Johanna C Herkert, et al. · European Journal of Human Genetics · 90

Cardiac Phenotypes, Genetics, and Risks in Familial Noncompaction Cardiomyopathy

2019 · Jaap I. van Waning, Kadir Caliskan, et al. · Journal of the American College of Cardiology · 87

Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience

2007 · M. Michels, Y. M. Hoedemaekers, et al. · Netherlands Heart Journal · 43

Mortality Risk of Untreated Myosin-Binding Protein C–Related Hypertrophic Cardiomyopathy

2011 · Eline A. Nannenberg, Michelle Michels, et al. · Journal of the American College of Cardiology · 30

Prenatal ultrasound diagnosis of MYH7 non‐compaction cardiomyopathy

2012 · Y. M. Hoedemaekers, T. E. Cohen‐Overbeek, et al. · Ultrasound in Obstetrics and Gynecology · 26

A tailored approach to informing relatives at risk of inherited cardiac conditions: results of a randomised controlled trial

2021 · Lieke M. van den Heuvel, Yvonne M. Hoedemaekers, et al. · European Journal of Human Genetics · 21

The First Titin (c.59926 + 1G > A) Founder Mutation Associated with Dilated Cardiomyopathy

2017 · Edgar T. Hoorntje, Karin Y. van Spaendonck-Zwarts, et al. · European Journal of Heart Failure · 19

Screening, diagnosis and follow-up of Brugada syndrome in children: a Dutch expert consensus statement

2022 · P. J. Peltenburg, Y. M. Hoedemaekers, et al. · Netherlands Heart Journal · 18

Cardiac aldosterone in subjects with hypertrophic cardiomyopathy

2006 · Wenxia Chai, Yvonne M Hoedemaekers, et al. · Journal of the Renin-Angiotensin-Aldosterone System · 18

Informing relatives at risk of inherited cardiac conditions: experiences and attitudes of healthcare professionals and counselees

2019 · Lieke M. van den Heuvel, Mette J. Huisinga, et al. · European Journal of Human Genetics · 17

Diagnostic yield of targeted next generation sequencing in 2002 Dutch cardiomyopathy patients

2021 · Mohamed Z. Alimohamed, Lennart F. Johansson, et al. · International Journal of Cardiology · 16

Untargeted Metabolomics Identifies Potential Hypertrophic Cardiomyopathy Biomarkers in Carriers of MYBPC3 Founder Variants

2023 · Mark Jansen, Maike Schuldt, et al. · International Journal of Molecular Sciences · 15

Three female patients with Danon disease presenting with predominant cardiac phenotype: a case series

2019 · Bart A Mulder, Yvonne M Hoedemaekers, et al. · European Heart Journal - Case Reports · 10

Circulating Acylcarnitines Associated with Hypertrophic Cardiomyopathy Severity: an Exploratory Cross-Sectional Study in MYBPC3 Founder Variant Carriers

2023 · Mark Jansen, A. F. Schmidt, et al. · Journal of Cardiovascular Translational Research · 9

Functional investigation of two simultaneous or separately segregating DSP variants within a single family supports the theory of a dose‐dependent disease severity

2022 · Mathilde C. S. C. Vermeer, Daniela Andrei, et al. · Experimental Dermatology · 8

BIO FOr CARE: biomarkers of hypertrophic cardiomyopathy development and progression in carriers of Dutch founder truncating MYBPC3 variants—design and status

2021 · M. Jansen, I. Christiaans, et al. · Netherlands Heart Journal · 8

Works count: 55

Citation count: 2,571

H-index: 18

I10-index: 22